In the cochlea, Ca v 1.3 voltage-gated Ca 2+ channels are essential for the proper development and function of inner hair cells (IHCs) as mechanosensory transducers of acoustic stimuli. Ca v 1.3 channels mediate L- type Ca 2+ currents that trigger exocytosis of neurotransmitter from IHCs onto auditory nerve afferents (Platzer et al. 2000; Brandt et al. 2003 Brandt et al. , 2005 and Ca 2+ action potentials in IHCs before the onset of hearing (Brandt et al. 2003;  currents (I Ca ) than Ba 2+ currents (I Ba ) and depends on calmodulin binding to the IQ domain in the C-terminal domain of the pore-forming Ca v 1 α 1 -subunit (Qin et al. 1999; Peterson et al. 1999; Zühlke et al. 1999) . Mutations of the IQ domain in the Ca v 1.3 α 1 -subunit (α 1 1.3) inhibit CDI, and a α 1 1.3 splice variant lacking the IQ domain was identified in the cochlea (Shen et al. 2006) . However, this α 1 1.3 variant is expressed mainly in outer hair cells (OHCs) and not IHCs, suggesting an alternative mechanism for the limited CDI of native Ca v 1.3 channels in IHCs.
We have shown previously that Ca 2+ binding proteins related to calmodulin (CaBP1 and CaBP4) can physically displace calmodulin from Ca v channels, but with distinct functional consequences (Lee et al. 2002; Zhou et al. 2004; Haeseleer et al. 2004; Zhou et al. 2005) . CaBP1 is expressed primarily in the brain and retina and abolishes CDI of Ca v 1.2 channels (Zhou et al. 2004 (Zhou et al. , 2005 . CaBP4 is localized in photoreceptor nerve terminals, where its association with Ca v 1.4 causes the channels to activate at more hyperpolarized membrane potentials required for normal visual transduction . Considering the analogous functions of Ca v 1.3 in IHCs and Ca v 1.4 in photoreceptors, we hypothesized that CaBP4 might be expressed in IHCs and confer the native phenotype of Ca v 1.3 Ca 2+ current in these cells. Evidence favouring this hypothesis was provided in a recent study (Yang et al. 2006) . Here, we further investigated the role of CaBPs in the regulation of Ca v 1.3 Ca 2+ currents in IHCs. Our results show that CaBP4 has relatively minor effects on Ca v 1.3 CDI, which alone cannot account for the slowly inactivating properties of Ca v 1.3 in IHCs. Instead, the data implicate CaBP1 as a key candidate for regulating CDI in IHCs.
Methods

Ethical approval
All procedures involving animals were approved by the Institutional Animal Care and Use Committee at Emory University in accordance with National Institutes of Health guidelines and animal welfare guidelines at the University of Göttingen and the State of Lower Saxony. After killing the mice by cervical dislocation the skull was opened, and the cochlea was removed and opened at the apex so that the apical coil could be harvested for immuncytochemical or electrophysiological experiments.
Constructs and molecular biology
The following Ca v subunit cDNAs were used: α 1 1.3 containing exon 42 (GenBank no. AF370009 and AF370010 for additional sequence encoded by exon 42), β 1b (GenBank no. NM017346), α 1 1.2 (GenBank no. M67515), β 2A (GenBank no. NM053581), β 3 (GenBank no. NM012838), β 4 (GenBank no. L02315), and α 2 δ (GenBank no. M21948). FLAG-α 1 1.3 and GST (glutathione-S-transferase)-tagged α 1 1.3 C-terminal construct (GST-α 1 1.3 CT: nucleotides 5886-6465) were previously described (Calin-Jageman et al. 2007 ). The I-E mutation was introduced at position 1608 in α 1 1.3 and CT by quick-change mutagenesis with specific oligonucleotide primers. GST-NT corresponds to amino acids 1-117 of α 1 1.3 subcloned into BamHI/NotI sites of pGEX4T-1. CaBP1, CaBP2, CaBP4 and CaBP5 constructs used for mammalian cell expression were previously described Zhou et al. 2004) .
Cell culture, transfection, and lysate preparation
Culture and transfection of HEK293T cells by Geneporter transfection reagent (Genlantis, San Diego, CA, USA) was as previously described (Calin-Jageman et al. 2007) . For immunoprecipitation, HEK293T cells were transfected with cDNAs encoding Ca v 1.3 (FLAG-α 1 1.3 (6 μg), β 2A , and α 2 δ (2 μg each) with or without CaBP4 (2 μg). For electrophysiological experiments, HEK293T cells plated on 35 mm dishes were transfected with ∼3 μg total DNA (FLAG-α 1 1.3 or FLAG-α 1 1.2 (1.5 μg), β (0.8 μg), α 2 δ (0.8 μg) ± GFP-tagged CaBP1 (0.1 μg), GFP-tagged or untagged CaBP4 (0.1 μg) or GFP expression plasmid (0.01 μg)). These transfection conditions have been optimized to compensate for the inhibitory effect of CaBPs on Ca v current density, and yield measurable whole-cell currents (0.1−0.5 nA) that are easily amenable to biophysical analysis. For electrophysiological recording, GFP fluorescence was used to identify cells cotransfected with Ca v 1 subunits and CaBPs. Due to the inherently weak fluorescence associated with the GFP-tagged CaBP4 construct, we generally used untagged CaBP4 in combination with GFP expression plasmid (0.01 μg) for detection of cotransfected cells. Since there was no significant difference in the effects of GFP-CaBP4 or untagged CaBP4, data resulting from both transfection methods were pooled.
Binding and coimmunoprecipitation assays
Methods for pull-down of CaBP1 or CaBP4 from transfected HEK293T cell lysates by GST-α 1 1.3 proteins immobilized on beads were published previously (Zhou et al. 2005; Zhou et al. 2004) . Co-immunoprecipitation of Ca v 1.3 and CaBP4 from transfected HEK293T cells was also as previously described (Calin-Jageman et al. 2007) . Western blotting was performed with appropriate antibodies (CaBP1 1 : 1000, CaBP4 1 : 2000) followed by HRP-conjugated anti-rabbit antibodies (1 : 2000) and enhanced chemiluminescent detection reagents (Amersham Biosciences, Piscataway, NJ, USA).
Immunohistochemistry
For Figs 1A and B and 5B, C and E and online supplemental material Supplemental Fig. 1b (CaBP2 and CaBP5) , immunostaining and confocal analysis of whole-mount mouse organ of Corti (P14-15, P28, or 2 months old as indicated) were performed essentially as described (Sendin et al. 2007 ). The following antibodies were used: mouse anti-CtBP2 IgG1 (1 : 200; BD Biosciences, San Jose, CA, USA), anti-CaBP2, 4 and 5 (1 : 400 (Haeseleer et al. 2000) and AlexaFluor488-and AlexaFluor568-labelled secondary antibodies (1 : 200; Invitrogen, Carlsbad, CA, USA). For Fig. 5A and Supplemental Fig. 1a and b (CaBP1), cochleae were fixed with 4% paraformaldehyde/phosphate-buffered saline (PBS) and decalcified with 10% EDTA/PBS for 24 h prior to immunostaining with rabbit anti-CaBP1 or CaBP4 antibodies (Haeseleer et al. 2000; 1 : 500) and FITC donkey anti-rabbit IgG (1 : 200; Jackson ImmunoResearch, West Grove, PA, USA). Before mounting, most samples were incubated in Hoechst 34580 (1 : 1000, Invitrogen) for 5-10 min. Confocal images were acquired using a Leica SP2 or SP5 (Leica Microsystems, Mannheim, Germany) or Zeiss LSM 510 laser scanning confocal microscope. Processed images were assembled for display in Adobe Photoshop and Illustrator or Macromedia Freehand software.
RT-PCR
RNA was isolated from mouse (P14) cochlea with Trizol reagent (Invitrogen) and subject to RT-PCR with primers specific for CaBP1, 2, 4, or 5. Amplification of CaBP1 was performed with standard primers, while that for CaBP2, 4, and 5 required nested primers. Amplicons were analysed on agarose gels and were detected alongside negative control reactions that lacked reverse transcriptase. The following primer sets were used: CaBP1 forward: GACAAAGACAAGGATGGTTAC, reverse: CTCTTCAA-AGTCCACTCGTCC; CaBP2 forward 1: ATGGTTCAG-AGACCCATGG, reverse 1: CCGAGACATCATCCGA-ACAAA, forward 2: GCATGCATCTTCCTTCGACCC, reverse 2: GGTCAATGTCTTGGAGTATC; CaBP4 forward 1: GAGTTTGACACTGACCAGGAC, reverse 1: CTCGTC-AAAGTCTATGGTGC, forward 2: CAGCACGTGAAG-ATGCGCATG, reverse 2: CAACATCTCATCCAGTTCA-GTG; CaBP5 forward 1: ATGCAGTTTCCAATGGGTC-CTG, reverse 1: CGAGACATCATCTTCACAAACA, forward 2: CAGGATGAGCTTGATGAGCTC, reverse 2: TGCTGCAG TTCT GCCAGTGT.
Electrophysiology
Electrophysiological data were acquired with EPC-9 patch-clamp amplifiers driven by Pulse software (HEKA Elektronik, Lambrecht/Pfalz, Germany) and analysed with Igor Pro software (Wavemetrics, Lake Oswego, OR, USA). For transfected HEK293T cells, extracellular recording solutions contained (mm): 150 Tris, 1 MgCl 2 , and 10 BaCl 2 or 10 CaCl 2 . Intracellular solutions consisted of (mm): 140 N -methyl-d-glucamine, 10 Hepes, 2 MgCl 2 , 2 Mg-ATP, and 5 EGTA. The pH of intracellular and extracellular recording solutions was adjusted to 7.3 with methanesulphonic acid. Electrode resistances were typically 1-2 M in the bath solution, and series resistance was ∼2-4 M , compensated up to 80%. Current density was measured by dividing the amplitude of the Ca 2+ current by the cell capacitance. For this purpose, the Ca 
where g is the maximum conductance, V is the test potential, E is the apparent reversal potential, V 1/2 is the potential of half-activation, k is the slope factor, and b is the baseline. Statistical comparisons were by t test.
For IHCs, perforated patch-clamp recordings were made from the apical coil of freshly dissected organs of Corti from NMRI, C57Bl/6, or CaBP4 −/− mice (2-4 weeks of age) at the basolateral face of IHCs at room temperature. The intracellular recording solutions contained (mm), for exocytosis: 140 caesium gluconate, 13 TEA-Cl, 10 CsOH-Hepes; for CDI: 130 caesium gluconate, 10 TEA-Cl, 10 4-AP, 10 NaOH-Hepes, 1 MgCl 2 . Both solutions contained amphotericin B (250 μg ml −1 ). The extracellular solutions contained (mm), for exocytosis: 105 NaCl, 35 TEA-Cl, 2.8 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 NaOH-Hepes, 10 d-glucose; for CDI: 104 NaCl, 35 TEA-Cl, 2.8 KCl, 1 MgCl 2 , 1 CsCl, 5 4-AP, 10 NaOH-Hepes, 10 d-glucose and 5 Ca 2+ or 5 Ba 2+ . All solutions were adjusted to pH 7.2. With these solutions, electrode resistances were typically 4-6 M . All voltages were corrected for liquid junction potentials. C m was measured as previously described (Moser & Beutner, 2000) and C m was estimated as the difference between the mean C m over 60-400 ms after the end of the depolarization and the mean prepulse capacitance (400 ms). Integrals of the Ca 2+ current were calculated from the total depolarization-evoked inward current, including Ca 2+ tail currents after leak subtraction. Cells with a membrane current exceeding −50 pA at the standard holding potential of −86 mV were discarded from the analysis.
All averaged data are presented as the mean ± s.e.m. Statistical significance of differences between two groups was determined by Student's t test or ANOVA as indicated (SigmaStat, Systat Software Inc., San Jose, CA, USA).
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In vivo analysis of auditory function in CaBP4 +/− and CaBP4 −/− mice
The development and characterization of CaBP4
−/− mice were previously described . For auditory brainstem responses (ABR) and distortion product otoacoustic emissions (DPOAE), mice (4 weeks old) were measured essentially as previously described . Briefly, for ABR, tone bursts (4/6/8/12/16/24/32 kHz, 10 ms plateau, 1 ms rise/fall) or clicks (of 0.03 ms) were applied in the free field at 20 Hz (System 2, Tucker-Davis Technology, Gainesville, FL, USA and high frequency speaker: Monacor International, Bremen, Germany). Intensities are displayed as sound pressure level (dB root mean square for tone bursts, dB peak equivalent for clicks). Thresholds were estimated with 10 dB precision by visual inspection of average ABR traces.
Results
CaBP4 interactions with Ca v 1.3
By immunohistochemistry, CaBP4 was expressed in both IHCs and OHCs after the onset of hearing ( Fig. 1A ), while it was absent early in development (P0, data not shown). Within P15 IHCs, CaBP4 labelling was distributed throughout the soma (Fig. 1A) , which was also the case at later ages (P28; online supplemental material, Supplemental Fig. 1a ). CaBP4 immunofluorescence was not restricted to presynaptic sites, identified by double-labelling with antibodies against CtBP2 (Fig. 1A) . The absence of CaBP4 immunofluorescence in IHCs from CaBP4 −/− mice ( Fig. 1B and Supplemental Fig. 1a ) confirmed the specificity of the antibodies for detecting CaBP4 in cochlear tissue.
Next, we tested if CaBP4 directly interacts with Ca v 1.3 in pull-down assays with GST-tagged fragments of α 1 1.3. We focused on the cytoplasmic N-terminal (NT) and C-terminal (CT) domains of α 1 1.3 (Fig. 1C) , since they serve as the primary CaBP interaction sites in other Ca v α 1 subunits (Lee et al. 2002; Haeseleer et al. 2004; Zhou et al. 2004 Zhou et al. , 2005 . In these experiments, CaBP4 associated with NT and CT, but not the GST control both in the presence and absence of Ca 2+ (Fig. 1D ). Ca 2+ -independent association of CaBP4 with the intact channel was also shown by coimmunoprecipitation from lysates of HEK293T cells (Fig. 1E) . Together with previous findings that CaBP1 and CaBP4 do not require Ca 2+ for binding to Ca v channels (Lee et al. 2002; Haeseleer et al. 2004; Zhou et al. 2004; Zhou et al. 2005) , these results suggest that CaBPs are constitutive subunits of Ca v channels under basal Ca 2+ conditions. Since the NT and CT are modulatory sites for CDI in Ca v 1.2 (Ivanina et al. 2000; Zhou et al. 2005) , we tested if CaBP4 binding to these regions affects CDI of Ca v 1.3. Inactivation was measured as I res /I pk , which was the current amplitude at the end of a 300 ms test pulse normalized to the peak current amplitude. CDI was calculated as the difference between I res /I pk for I Ca and I Ba . CaBP4 caused a small but significant inhibition of CDI (∼13% compared to Ca v 1.3 alone, P < 0.0001; Fig. 2A ).
CaBP4 inhibited inactivation of I Ca (I res /I pk = 0.21 ± 0.02 for Ca v 1.3 + CaBP4 versus 0.14 ± 0.01 for Ca v 1.3 alone; P < 0.001) but not I Ba (I res /I pk = 0.91 ± 0.02 for Ca v 1.3 + CaBP4 versus 0.95 ± 0.01 for Ca v 1.3 alone; P = 0.06), indicating a selective effect on CDI. However, CDI was still quite prominent in cells cotransfected with CaBP4 and Ca v 1.3 ( Fig. 2A) . CaBP4 also caused a modest inhibition Test pulses were 300 ms steps from −90 to −20 mV for Ca v 1.3 or 1 s steps from −80 to −10 mV for Ca v 1.2. Inactivation was measured as I res /I pk , which was the residual current amplitude at the end of the pulse normalized to the peak current amplitude. CDI is the difference in I res /I pk for I Ca and I Ba . Representative current traces for I Ca (black or red) and I Ba (grey) are shown. * P < 0.01 compared to I Ba by t test; * * P < 0. of CDI for Ca v 1.2 ( Fig. 2A) , but this was in contrast to the complete blockade of Ca v 1.2 CDI caused by CaBP1 (Zhou et al. 2005; Zhou et al. 2004) .
In these experiments and as noted previously (Yang et al. 2006) (Fig. 2B) . For both groups, the relationship between current amplitude and I res /I pk was linear, with a slope not significantly different from zero. Thus, like Ca v 1.2 channels (Neely et al. 1994) , CDI of Ca v 1.3 is independent of channel expression levels, perhaps due to a reliance on very local increases in Ca 2+ through individual channels. This result argues against a role for the CaBP4-mediated decrease in current density in the mechanism by which CaBP4 inhibits CDI.
Because modulation of CDI can vary with the identity of the auxiliary Ca v β subunit (Lee et al. 2000) , we tested if CaBP4 might have stronger effects on CDI of Ca v 1.3 channels comprised of different β subunits. CaBP4 caused a significant but still modest level of inhibition of I Ca inactivation in channels with β 1 , β 2 and β 4 without any effects on I Ba (Fig. 3) . Interestingly, CaBP4 did not influence inactivation of I Ca for Ca v 1.3 channels containing β 3 . In contrast to the stimulatory effects of CaBP4 on voltage-dependent activation of Ca v 1.4 ), CaBP4 did not similarly influence Ca v 1.3 channels, regardless of Ca v β ( Table 2 ). In addition, the negative effects of CaBP4 on current density were significant only for Ca v 1.3 channels containing Ca v β 2 (Table 1 ). These data indicate that CaBP4 differentially modulates Ca v 1.3 compared to Ca v 1.4, and has weak modulatory effects on CDI for Ca v 1.3 containing most Ca v β subunits.
Normal hair cell synaptic transmission in mice lacking CaBP4
To address the significance of CaBP4 as a modulator of auditory Ca v 1.3 channels, we tested if the absence of CaBP4 affected CDI of IHCs and sound coding at the IHC afferent synapses. Patch-clamp recordings of IHCs in the apical coil of the organ of Corti monitored I Ca and exocytic membrane capacitance changes ( C m ) reflecting neurotransmitter release (Moser & Beutner, 2000) from wild-type (WT, C57Bl/6) and CaBP4 were not different in WT and CaBP4 −/− IHCs (data not shown). As expected, analyses of I Ca integrals and C m (Fig, 4D and E) revealed that Ca 2+ influx and exocytosis were comparable in CaBP4 −/− and WT IHCs for depolarizations up to 200 ms ( Fig. 4D and E) .
Consistent with these findings, we found normal auditory brainstem responses (ABR) to click or short tone burst stimuli in CaBP4 −/− mice. ABR waveforms (Fig. 4F) , latencies (data not shown) and thresholds ( Fig. 4G) were not different from WT mice. Distortion product otoacoustic emissions were also unaltered in CaBP4 −/− mice, indicating intact cochlear amplification (data not shown). These findings confirm that CaBP4 is a relatively modest suppressor of Ca v 1.3 CDI in IHCs, but is not essential for normal IHC development and IHC function in auditory transduction.
CaBP1 is a candidate modulator of Ca v 1.3 CDI in IHCs
To explore alternative mechanisms for inhibiting CDI in IHCs, we assessed the expression other CaBP isoforms by immunohistochemistry in the mouse organ of Corti. In addition to that for CaBP4, immunolabelling for CaBP1, CaBP2 and CaBP5 was detected in IHCs (Fig. 5A-C) . The specificity of the immunostaining was supported by the substantial reduction of signal upon preadsorption of the CaBP antibodies with the corresponding immunogen ( Supplemental Fig. 1b) . The expression of CaBP1, CaBP2 and CaBP4 in cochlear extracts was confirmed by RT-PCR analysis (Fig. 5D ). However, CaBP5 was not detected by this method perhaps due to the low expression levels of CaBP5 relative to other CaBPs in IHCs. Interestingly, CaBP1 showed a punctate distribution at the base of IHCs from older mice (P28, data not shown, and 2 months old; Fig. 5E ) in contrast to the diffuse localization of CaBP1 in IHCs from younger mice (P14; Fig. 5A ). The CaBP1-labelled puncta strongly colocalized with labelling for CtBP2. These data suggested the likely colocalization of CaBP1 with presynaptic Ca v 1.3 channels, which show a similar subcellular distribution (Brandt et al. 2005) . The presynaptic localization of CaBP1 was qualitatively similar in CaBP4 −/− IHCs (Fig. 5E , lower panels). If CaBP1 more prominently suppressed CDI of Ca v 1.3 in IHCs, CaBP1/Ca v 1.3 interactions could explain the relatively normal auditory phenotype in CaBP4 −/− mice. To test this, we compared the capacities of CaBP1, 2 and 5 as modulators of Ca v 1.3 CDI in transfected HEK293T cells. While CaBP5 had modest effects on CDI that were not significantly different from those of CaBP4 (P = 0.94), CaBP2 had no impact in this regard (I res /I pk = 0.14 ± 0.01 for + CaBP2 versus 0.12 ± 0.01 for Ca v 1.3 alone; P = 0.42; Fig. 6 ). However, CaBP1 caused a significantly stronger suppression of CDI than CaBP4 (P < 0.001; Fig. 6 ). Similar to CaBP4, CaBP1 interacted with the NT and CT of α 1 1.3 in a Ca 2+ -independent manner in pull-down assays (Fig. 7A) . Thus, while CaBP1 and CaBP4 may bind to the same sites in α 1 1.3, they exhibit distinct modulatory strengths with respect to inactivation of I Ca .
Our electrophysiological results could also be explained by differences in the relative expression levels and/or transfection efficiency of CaBP1 and CaBP4. To address these possibilities, we performed Western blot analyses of lysates of cells transfected with Ca v 1.3 alone or cotransfected with CaBP1 or CaBP4. To control for differences in immunoblotting efficiencies of CaBP1 and CaBP4 antibodies, signals were qualitatively compared to those corresponding to known quantities of the J Physiol 585.3 purified proteins. With this approach, we consistently observed lower levels of CaBP4 than CaBP1 in transfected cell lysates (Fig. 7B) . However, when GFP-tagged CaBP1 or CaBP4 constructs were cotransfected with Ca v 1.3 as Figure 4 . Hearing is not impaired in CaBP4 knockout mice A and B, mean I Ca (A) and I Ba (B) of WT (black, n = 12) and CaBP4 −/− (grey, n = 14) IHCs evoked by 500 ms depolarizations to −16 mV. Currents were normalized to their peak amplitude and displayed with standard errors. C, I res /I pk and CDI were determined as in Fig. 2A except that currents were evoked as in (A and B) and residual current amplitude was measured at 300 ms. D, representative I Ca and baseline-subtracted C m traces (200 ms step to −16 mV). E, grand average of C m (top) and I Ca integrals (bottom) plotted against pulse duration for WT (n = 25) and CaBP4 −/− (n = 7) IHCs. F, grand average of ABR evoked by suprathreshold clicks (80 dB) in WT (black) and CaBP4 −/− mice (grey). Roman numerals denominate the individual ABR peaks arising from the neurons of the ascending auditory pathway. G, ABR audiograms of WT (black) and CaBP4 −/− mice (grey) obtained by tone burst and click stimulation.
for electrophysiological experiments, we did not find significantly weaker transfection efficiency of CaBP4 compared to CaBP1 (Fig. 7C upper panels) . We did note that GFP-CaBP4 fluorescence was generally weaker and diffusely localized, in contrast to the strong localization of GFP-CaBP1 at the plasma membrane (Fig. 7C, lower  panels) . These results suggest that the weak effects of CaBP4 in modulating Ca v 1.3 could be influenced by limited cell-surface targeting and/or lower expression levels of CaBP4 compared to CaBP1 in transfected cells.
Differential modulation of Ca v 1.3 CDI by CaBP4 and CaBP1
The distinct effects of CaBP1 and CaBP4 could also be mediated by separate molecular determinants for each in the NT or CT of α 1 1.3. If so, then alterations in the NT or CT should differentially affect modulation by CaBP1 and CaBP4. To test this, we initially deleted portions of the NT from α 1 1.3, since similar deletions in α 1 1.2 abolished modulation of Ca v 1.2 by CaBP1 (Zhou et al. 2005) . Small and large deletions of the α 1 1.3 NT resulted in non-functional channels, which precluded functional analyses of this region. Therefore, we focused our efforts on the α 1 1.3 CT and substituted the isoleucine with glutamate in the IQ domain in the CT, since similar mutations in α 1 1.2 inhibit binding and modulation of Ca v 1.2 by CaBP1 (Zhou et al. 2004 (Zhou et al. , 2005 . Consistent with the essential role of the IQ domain in transducing CDI of Ca v 1 channels (Peterson et al. 1999; Zühlke et al. 1999 ; Qin et al. 1999) , the I-E mutation disrupted, although not completely, CDI of Ca v 1.3 (Ca v 1.3I-E, Fig. 8A ). In addition, GST-tagged CT fusion proteins containing the I-E mutation showed weaker binding to CaBP4 and CaBP1 in pull-down assays (Fig. 8B) , which suggested that Ca v 1.3I-E would show limited regulation by these CaBPs. While Ca v 1.3I-E channels were completely insensitive to modulation by CaBP4 (Fig. 9A and B) , there were residual effects of CaBP1 in that I Ca inactivated ∼2 times less in cells transfected with Ca v 1.3I-E + CaBP1 than with Ca v 1.3 alone (P < 0.001; Fig. 9C ).
Unexpectedly, and in contrast to CaBP4, CaBP1 significantly inhibited voltage-dependent inactivation (VDI) exhibited by I Ba (∼36% compared to Ca v 1.3 alone, P < 0.001). In these experiments, CaBP regulation of VDI was probed with channels containing the Ca v β 1 subunit, which show more prominent VDI than those with Ca v β 2 (compare Fig. 9B to Fig. 2A) . The effect of CaBP1 on VDI was completely spared by the I-E mutation (P = 0.23 for Ca v 1.3 versus Ca v 1.3I-E; Fig. 9D ). During longer depolarizations (1 s), the inhibitory effect of CaBP1 on VDI was particularly apparent. While CaBP4 had no effect on inactivation of I Ba (I res /I pk = 0.29 ± 0.03 for Ca v 1.3 + CaBP4 versus 0.34 ± 0.03 for Ca v 1.3 alone; P = 0.86), CaBP1 caused I Ba to inactivate significantly less than in cells transfected with Ca v 1.3 alone or cotransfected with CaBP4 (Fig. 9E ). These data reveal distinct molecular mechanisms by which CaBP1 and CaBP4 regulate Ca v 1.3 inactivation: while required for effects of CaBP4 on I Ca , the IQ domain is necessary but not sufficient for the full modulation of I Ca and I Ba by CaBP1. Our results extend but also differ from those of Yang et al. (2006) , who found that CaBP4 and CaBP1 both abolished CDI of Ca v 1.3 channels in transfected HEK293 cells. We employed the long variant of α 1 1.3 with exon 42, which contains an additional ∼500 amino acids downstream of the IQ domain compared to the shorter α 1 1.3 variant with exon 42A (Xu & Lipscombe, 2001) 
inhibits CDI and binding of CaBP1 and CaBP4
A, effect of I-E mutation on CDI. HEK293T cells were transfected with wild-type Ca v 1.3 or channels containing α 1 1.3 with I-E substitution in IQ domain (+β 1b , α 2 δ). Same analysis as in Fig. 2A for CDI. * P < 0.001 compared to I Ba ; * * P < 0.001 compared to Ca v 1.3; by t test. Number of cells indicated in parentheses. B, effect of I-E mutation on CaBP binding. Pull-down of CaBP1 or CaBP4 by GST, CT, or CT containing I-E mutation was performed as in Fig. 7A . Results shown are representative of 3 experiments. not shown). The discrepancy may arise from the use of an inducible CaBP4 expression system in which high levels of Ca v 1.3 expression by transient transfection were achieved prior to induction of CaBP4 in the previous study. This method, and higher permeant ion concentrations (20 mm versus 10 mm in our study) during electrophysiological recordings, overcomes the inhibitory effects we have noted of CaBPs on Ca v expression levels (Lee et al. 2002; Zhou et al. 2004) . At the same time, this approach may also mask functional differences in CaBPs, which might prevail under non-saturating CaBP expression levels, such as in our experiments where Ca v 1.3 was transiently cotransfected with CaBP1 or CaBP4.
In transfected cells, the decreased plasma membrane targeting of CaBP4 compared to CaBP1 may limit the modulatory potential of CaBP4. Unlike CaBP4, CaBP1 is N-terminally myristoylated (Haeseleer et al. 2000) , which may aid in its cell-surface targeting and coassembly with Ca v 1.3 channels. Lack of this modification may weaken CaBP4 interactions with functional Ca v 1.3 channels, which may negatively influence the stability and net expression levels of CaBP4 in cotransfected cells. While electrophysiological analysis with Ca v 1.3I-E mutants suggest fundamental distinctions in how CaBP1 and CaBP4 interact with Ca v 1.3 channels, we cannot rule out that differential expression/targeting of these CaBPs also contributes to their strengths as Ca v 1.3 modulators.
Regardless of how differences in CaBP4 and CaBP1 in IHCs influence their roles in Ca v 1.3 regulation, our results argue against CaBP4 as the primary regulator of Ca v 1.3 in IHCs. Mouse IHCs lacking CaBP4 showed only a minor increase in CDI, indicating that CaBP4 is not essential for, but may contribute to, the peculiar slow CDI of Ca v 1.3 channels in IHCs. This may reflect the relatively weak effects of CaBP4 as a Ca v 1 modulator and/or limited presynaptic targeting/expression levels compared to other CaBPs. The dispensability of CaBP4 for hair cell sound coding is further demonstrated by the normal auditory brainstem responses in mice lacking CaBP4. The auditory physiology of CaBP4 −/− mice was conducted at an age when CaBP1 is strongly localized presynaptically both in WT and CaBP4 −/− IHCs. The less intense immunolabelling of CaBP1 in adult IHCs may have been missed by Yang et al. leading to their conclusion that CaBP4 was the critical modulator of Ca v 1.3 function at later ages (Yang et al. 2006) . The use of cryosections in the previous study may have impaired detection of punctate labelling in adult IHCs, since only a few puncta might be visible in a single IHC with this method. In our experiments, presynaptic labelling was readily apparent in an entire row of IHCs in projections of confocal micrographs. Why CaBP1 exhibits a diffuse localization in P14 IHCs and becomes presynaptically clustered at later ages is not clear, but clearly allows CaBP1 to be well-situated to modulate Ca v 1.3 channels.
We also note that in transfected cells, CaBP1 not only strongly suppresses CDI (inactivation of I Ca ) but also inhibits VDI (inactivation of I Ba ), which was not seen with CaBP4 (Fig. 9 ). This latter point is relevant since Ca v 1.3 currents in IHCs show dramatically slower CDI and VDI than in recombinant systems (Platzer et al. 2000; Koschak et al., 2001) . The fact that cotransfection of Ca v 1.3 with CaBP1 fully reproduces the native properties of Ca v 1.3 channels further implicates CaBP1 as a modulator of Ca v 1.3 in IHCs, which may support the crucial roles of Ca v 1.3 channels in hearing.
